会社概要
- 正式社名: RODI FERTILITY
- 登録国: Cyprus
- 住所: Lapithou 14, office 206A, Engomi-Nicosia,, Nicosia
- 従業員数: 1 - 24
説明:
RODI Fertility leads global innovation with patented immunomodulatory technology that regulates Natural Killer (NK) cells, a breakthrough in preventing miscarriage and supporting conception, offering first-in-class NK cell regulation for successful pregnancy. Its flagship product, RODI NK plus, has helped thousands of women achieve successful pregnancies through scientifically proven NK cell balance, with a portfolio also including RODI NK, RODI OVA and RODI VITA.
事業活動
ATC分類(解剖治療化学分類)
早期段階の企業（スタートアップ）
販売市場
- Western Asia: , , ,
- Northern Europe: , , , , , ,
- Southern Europe: , , , , , ,
- Eastern Europe:
当社の製品・サービス
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
認証
GMP
ISO
証明
CPHI Americas 2026
06/2026 – 06/2026
CPHI Americas 2026
評価
(0)
(0)
(0)
(0)
(0)
コメント
フィルター:
並べ替え:
コメントはありません。
評価とコメントを残す